Nobuaki Adachi

Years Active: 2017-2021
Publications (10 Years): 2

Daiichi Sankyo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Daiichi Sankyo Oct 01 2000

Japan

Director :: Oncology Medical Science Department

Publications

Yuki Kagiyama, Shuhei Fujita, Yutaka Shima, Kazutsune Yamagata, Takuo Katsumoto, Makoto Nakagawa, Daisuke Honma, Nobuaki Adachi, Kazushi Araki, Ayako Kato, Koichiro Inaki, Yoshimasa Ono, Suguru Fukuhara, Yukio Kobayashi, Kensei Tobinai, Issay Kitabayashi
CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib. Cancer science 112 (6) (2021)
Daisuke Honma, Osamu Kanno, Jun Watanabe, Junzo Kinoshita, Makoto Hirasawa, Emi Nosaka, Machiko Shiroishi, Takeshi Takizawa, Isao Yasumatsu, Takao Horiuchi, Akira Nakao, Keisuke Suzuki, Tomonori Yamasaki, Katsuyoshi Nakajima, Miho Hayakawa, Takanori Yamazaki, Ajay Singh Yadav, Nobuaki Adachi
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor. Cancer science 108 (10) (2017)

Nobuaki Adachi.css-eqlu8i{font-size:small;padding-left:4px;}